65,437 trials
Chronic Myelogenous Leukemia · Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive) · Hypereosinophilic Syndrome
Primary: Number of Participants With Major Cytogenetic Response (MCyR) — 191; 44; 22 Participants
Synovial Sarcoma · Single or Multiple Lung Metastases
Primary: Number of Participants Evaluated for Toxicity — 10 Participants
Coronary Disease
Primary: Major Adverse Cardiovascular Events — 0 Participants
Acne Scars - Mixed Atrophic and Hypertrophic · Wrinkle
Primary: Overall Wrinkle Improvement Assessed by the Fitzpatrick Wrinkle and Elastosis Scale (FWES) at 12 Weeks Post-Final Treatment — 5.97; 5.78 units on a scale
Carcinoma, Intraductal, Noninfiltrating · DCIS · Ductal Carcinoma In Situ
Primary: Average Change in the Longest Diameter of the Breast MRI Target Lesion — 6; 43 percentage length change
Dry Eye Syndromes
Primary: Number of Subjects With Blurred Vision After Instillation — 0; 10; 0; 21 participants
Cognitive Impairment, Mild · Depressive Symptoms · Anxiety
Primary: Cognitive and Memory Function — 56.5; 49.8 score on a scale
Recurrent Squamous Cell Lung Carcinoma · Stage IV Squamous Cell Lung Carcinoma AJCC V7
Primary: Overall Response Rate in Participants With c-Met Positive Lung Squamous Cell Carcinoma (SCCA) — 9 percentage of participants
Heavy Drinking · Alcohol Dependence · Alcohol Use Disorder
Primary: Change in Percent Heavy Drinking Days (%HDDs) Over the Past 30 Days From Baseline to 3 Month Follow-up, Assessed Using the Timeline Follow-Back — -46.4; -38.4 change in…
Vitreomacular Traction (VMT) · Full-thickness Macular Holes (MH)
Primary: Proportion of Eyes With Macular Hole Closure of Inner Retinal Layers Without Rescue Vitrectomy — 10 Eyes
Stroke · Cerebrovascular Accident (CVA) · Hemiparesis
Primary: Median Absolute Change From Baseline in Electromyographic (EMG) Peak Amplitude of the Bicep/Tricep — 22.310; 7.010; 16.070; 10.055 percentage of MVC — p=0.002
Myopia
Primary: Overall Lens Fit Acceptance — 3.90; 3.81 units on a scale
Healthy Diet
Primary: Ad Libitum Energy Intake — 2963; 2491 kcal per day
Posttransplant Diabetes Mellitus
Primary: 2-hour Oral Glucose Tolerance Test-derived Blood Sugar — 141.00; 165.22 mg/dL
Stroke · Hemiparesis
Primary: Change From Baseline in Fugl-Meyer Arm (FMA) Motor Score — 37.8; 41.3; 47; 41.3 score on a scale